IMRN · Immuron Ltd
Market Cap
$9.28M
Shares
8.07M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.15
Open$1.15
Day$1.15–1.18
52W close$0.70–2.35
Avg vol 30d21K
Short int40K · 0.5% float · 2.3d
Short vol10%
Last earningsJun 30, 2022
DataJan 2020–Aug 2026
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+11%
above
Price vs 50-day avg
+1%
above
RSI (14)
53
neutral
MACD trend
Positive
52-week position
27%
mid-range
Momentum
relative strength
1-month return
+6%
trailing
6-month return
+38%
trailing
YTD return
+51%
this year
Relative strength
+24%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-14% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.49% of float · ▲ +10.3% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 3-yr range
Squeeze score
41
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
88%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
6.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+11%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
27%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-14% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.49% of float · ▲ +10.3% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 27%
Range high $2
vs 200-day avg +11%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMRN
this stock
Immuron Ltd
|
$9.28M | +50.7% | — | — | 0.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +19.5% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +2.9% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$63.63B | +21.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.23B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
6
- % held
- 1.0%
- Net QoQ
- -6.5K sh
- Top holder
- CITADEL ADVISORS LLC
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMRN | +2.7% | +5.5% | +37.7% | +5.5% | +50.7% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +2.2% | +2.5% | +24.3% | +2.5% | +37.9% |